Nautilus Biotechnology, Inc. (NAUT) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US63909J1088
Nautilus Biotechnology, Inc. financials
| Fiscal year | 2025 |
|---|---|
| EBIT | -59.00 m USD |
| Net income | -59.00 m USD |
| Diluted EPS – continuing operations | -0.47 USD |
Full history since 2018, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Nautilus Biotechnology, Inc.
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome in the United States. The company develops Nautilus Voyager Platform, which includes an end-to-end solution comprising instruments, reagents, consumables, and software analysis. It also provides nautilus voyager instrument, a high-resolution optical imaging system with integrated fluidics and liquid handling sub-system to deposit protein libraries onto a flow cell and to process labeled multi-affinity reagent binding and imaging cycles rapidly to decode and quantify the proteins present in biological samples. In addition, the company offers single-molecule library preparation kits, flow cells, affinity reagents, and instrument run buffers to perform multi-cycle analysis runs. It has a research collaboration agreement Genentech, Buck Institute, Allen Institute, Cornell University and the Qatar Foundation, and Michael J. Fox Foundation. Nautilus Biotechnology, Inc. was founded in 2016 and is headquartered in Seattle, Washington.
More stocks
- Nacity Property Service Co Ltd (603506.SS)
- Mining Americas Inc. (MAI.TO)
- AEON Co (Malaysia) Bhd (6599.KL)
- Finance of America Companies Inc. (FOA)
- Yulie Sekurindo Tbk (YULE.JK)
- ZheJiang HuaSheng Technology Co.Ltd (605180.SS)
- Westwing Group (WEW.DE)
- Shandong Swan Cotton (603029.SS)
- Radium Life Tech Co Ltd (2547.TW)
- Commerce.com, Inc. (CMRC)
- Argosy Research (3217.TWO)
- Chongqing New Dazheng Property Grp (002968.SZ)
Not investment advice. All data without warranty, price as of 05.11.2026. Details in the risk notice.